Systemic Toxicity of Intraperitoneal Vancomycin
Intraperitoneal vancomycin is used for empiric treatment of peritoneal dialysis peritonitis. It is dosed intermittently and a high systemic concentration is often achieved. Despite this, there are very few reports of systemic toxicity from intraperitoneal vancomycin. We report the course of a patien...
Saved in:
Main Authors: | Teerath Kumar, Iris Teo, Brendan B. McCormick |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Case Reports in Nephrology |
Online Access: | http://dx.doi.org/10.1155/2016/3968690 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biopsy-Proven Acute Tubular Necrosis due to Vancomycin Toxicity
by: Farheen Shah-Khan, et al.
Published: (2011-01-01) -
Hyperthermic intraperitoneal chemotherapy (HIPEC) increases risk of local anesthetic systemic toxicity (LAST)
by: Masahiko Tsuchiya, et al.
Published: (2025-01-01) -
Vancomycin-Associated Leukocytoclastic Vasculitis
by: Makhawadee Pongruangporn, et al.
Published: (2011-01-01) -
Navigating a Climate in Crisis through a Biomimetic Epistemology
by: Elizabeth McCormick, et al.
Published: (2024-12-01) -
Hyperthermic intraperitoneal chemotherapy: Ideal and reality
by: Fan-He Dong, et al.
Published: (2025-02-01)